The Treatment with Xinfeng Capsule Can Reduce the Risk of Readmission for Patients with Rheumatoid arthritis:A Cohort Study of Approximately 10000 Individuals
This study underscores a robust and long-term association between XFC usage and lower readmission rates among RA patients. As a protective factor against readmission risk in these patients, the clinical value of XFC merits further promotion and investigation.
Authors
- Jian Liu (ORCID: https://orcid.org/0000-0003-3101-7553)
- Fanfan Wang (ORCID: https://orcid.org/0000-0002-1824-9213)
- Mingyu He (ORCID: https://orcid.org/0000-0002-7047-8910)
- Yue Sun (ORCID: https://orcid.org/0000-0001-7903-3638)
- Yanyan Fang (ORCID: https://orcid.org/0000-0001-8754-7786)
Institutions
- Anhui University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- International Journal of General Medicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/ijgm.s491218
- Citations
- 2
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.94